Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial.

MLA

Leiter, Lawrence A., et al. “Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial.” Diabetes Care, vol. 38, no. 6, June 2015, pp. 1145–53. EBSCOhost, https://doi.org/10.2337/dc14-2868.

APA

Leiter, L. A., Teoh, H., Braunwald, E., Mosenzon, O., Cahn, A., Kumar, K. M. P., Smahelova, A., Hirshberg, B., Stahre, C., Frederich, R., Bonnici, F., Scirica, B. M., Bhatt, D. L., & Raz, I. (2015). Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial. Diabetes Care, 38(6), 1145–1153. https://doi.org/10.2337/dc14-2868

Chicago

Leiter, Lawrence A, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn, K M Prasanna Kumar, Alena Smahelova, et al. 2015. “Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial.” Diabetes Care 38 (6): 1145–53. doi:10.2337/dc14-2868.